Coronavirus Disease of 2019 in Patients With Well-Controlled Human Immunodeficiency Virus on Antiretroviral Therapy

J Acquir Immune Defic Syndr. 2020 Sep 1;85(1):e1-e4. doi: 10.1097/QAI.0000000000002415.

Authors

Rahul Shekhar¹, Ashley Barton², Abu Baker Sheikh¹, Shubhra Upadhyay¹, Natalie M Salas³

Affiliations

¹ Department of Internal Medicine, University of New Mexico Health Science Center, Albuquerque, NM.
² University of New Mexico School of Medicine, Albuquerque, NM.
³ Department of Infectious Disease, University of New Health Science Center, Albuquerque, NM.

Abstract

Supplemental Digital Content is Available in the Text.

Publication types

Letter

MeSH terms

Adult
Anti-Retroviral Agents / therapeutic use*
Betacoronavirus*
COVID-19
Coronavirus Infections / complications
Coronavirus Infections / epidemiology*
Female
HIV Infections / complications
HIV Infections / drug therapy*
HIV Infections / epidemiology
Humans
Incidence
Male
Middle Aged
New Mexico / epidemiology
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / epidemiology*
Prevalence
Retrospective Studies
SARS-CoV-2
Venous Thromboembolism / complications

Substances

Anti-Retroviral Agents